United Kingdom Hip Replacement Devices Market

Market Snapshot

• Market Size (2025): USD 219.7 Million
• Projected Market Size (2035): USD 270.9 Million
• Compound Annual Growth Rate (CAGR): 2.12%
• Base Year: 2025
• Historical Period: 2021–2024
• Forecast Period: 2026–2035

 

According to Decision Advisors, the United Kingdom Hip Replacement Devices Market Size was grown from USD 219.7million in 2025 to USD 270.9 million by 2035, at a CAGR of 2.12% during the forecast period 2026-2035. The United Kingdom hip replacement devices market is projected to grow significantly over the next decade due to rising geriatric numbers, obesity related joint issues, adoption of robotic-assisted surgery, an aging population, and technological advancements.

 

Market Overview/Introduction

The United Kingdom hip replacement devices market refers to the industry involved in the development, supply, and adoption of implants and surgical technologies used to replace damaged hip joints across the UK. The medical system provides treatment for multiple health conditions, which include osteoarthritis, fractures, and degenerative diseases, while it works to improve patient mobility and their entire body function. The United Kingdom hip replacement devices market is experiencing steady growth because of two factors, which include the growing elderly demographic and the rising number of people with osteoarthritis and hip-related disorders. The demand for surgical procedures increases because people develop joint problems from their rising obesity levels and their inactive way of living. Patient outcomes and recovery times have improved because of developments in implant materials and minimally invasive surgical methods. The National Health Service provides strong funding support, which results in high numbers of medical procedures, while public awareness and early detection methods drive market growth.

• Smith & Nephew is promoting its OR3O Dual Mobility system featuring OXINIUM DH (diffusion hardened) technology. This material is designed to reduce wear and the risk of dislocation, a leading cause of revision surgery

 

• Zimmer Biomet offered a comprehensive portfolio of hip products, spanning joint preservation to complex revision arthroplasty. These devices combined rich clinical heritage with modern advancements, addressed distinct patient needs, and simplified surgical workflows across the United Kingdom hip replacement market.

 

Notable Insights: -

1. The total hip replacement implants segment dominated the market in 2025 and holds the largest market share, accounting for approximately 50% during the forecast period.
2. The metal-on-polyethylene segment dominated the market in 2025 and holds the largest market share, accounting for approximately 40% during the forecast period.
3. The cementless fixation segment dominated the market in 2025 and holds the largest market share, accounting for approximately 49.9% during the forecast period.
4. The hospitals segment dominated the market in 2025 and holds the largest market share, accounting for approximately 70% during the forecast period.
5. The compound annual growth rate of the United Kingdom Hip Replacement Devices Market is 2.12%.
6. The market is likely to achieve a valuation of USD 270.9 million by 2035.

 

What is the role of technology in grooming the market?

Technology plays a pivotal role in shaping the United Kingdom hip replacement devices market by enhancing surgical precision, patient outcomes, and implant longevity. The adoption of robotic-assisted surgery and computer navigation systems enables highly accurate implant placement, reducing complications and recovery time. Advances in biomaterials, such as highly cross-linked polyethylene and ceramic components, improve durability and minimize wear. Additionally, 3D printing supports the development of patient-specific implants, ensuring better anatomical fit. Digital health tools, including AI-driven preoperative planning and remote monitoring, further streamline care delivery. Integration of smart implants and data analytics also allows clinicians to track performance, optimize treatments, and improve long-term success rates.

 

Market Drivers

The United Kingdom Hip Replacement Devices Market is being driven by a rapidly aging population, which is increasing the incidence of hip fractures and degenerative joint disorders. At the same time, the growing burden of lifestyle-related conditions such as obesity and osteoarthritis is significantly boosting the need for joint replacement procedures. Technological advancements, particularly in biomaterials, are enhancing implant durability and longevity, while the adoption of robotic-assisted surgical is improving procedural accuracy and patient outcomes. Additionally, the National Health Service (NHS) continues to support a high volume of hip arthroplasty procedures, although occasional manufacturing and supply chain disruptions may influence device availability.

 

Restrain

The United Kingdom Hip Replacement Devices Market faces restraints due to long surgical waiting times within the NHS, driven by resource constraints and backlog pressures. High procedure costs and budget limitations also restrict adoption. Additionally, supply chain disruptions and regulatory compliance requirements can delay product availability and market growth.

 

Strategies to Implement for Growth of the Market

• Expand surgical capacity within the National Health Service by increasing operating theatre availability and workforce to reduce waiting times.
• Invest in advanced technologies such as robotic-assisted surgery and AI-driven planning tools to improve precision and patient outcomes.
• Strengthen local manufacturing and supply chains to minimize disruptions and ensure consistent device availability.
• Promote the adoption of innovative biomaterials that enhance implant longevity and reduce revision surgeries.
• Encourage public-private partnerships to improve funding, infrastructure, and access to hip replacement procedures.
• Enhance surgeon training programs for minimally invasive and technology-assisted techniques.
• Implement value-based healthcare models focusing on long-term patient outcomes and cost efficiency.
• Increase awareness and early diagnosis of conditions like osteoarthritis to support timely intervention.

 

Market Segmentation

The United Kingdom hip replacement devices market share is classified into product type, material type, fixation type, and end-user  

 

• The total hip replacement implants segment dominated the market in 2025 and holds the largest market share, accounting for approximately 50% during the forecast period.

Based on the product type, the hip replacement devices market is divided into total hip replacement implants, partial hip replacement (hemiarthroplasty), hip resurfacing implants, and revision hip replacement implants. Among these, the total hip replacement implants segment dominated the market in 2025 and holds the largest market share, accounting for approximately 50% during the forecast period. The total hip replacement implants segment is driven by rising demand for advanced drug delivery systems in the UK, where polymers enhance stability, solubility, and controlled release. Growth in biologics, generics, and personalized medicines, along with strong pharmaceutical R&D and regulatory support, further accelerates the adoption of functional and multifunctional polymer excipients.

 

• The metal-on-polyethylene segment dominated the market in 2025 and holds the largest market share, accounting for approximately 40% during the forecast period.

Based on the material type, the hip replacement devices market is divided into metal-on-metal, metal-on-polyethylene, ceramic-on-polyethylene, and ceramic-on-ceramic. Among these, the metal-on-polyethylene segment dominated the market in 2025 and holds the largest market share, accounting for approximately 40% during the forecast period. The metal-on-polyethylene segment in the U.K. is driven by high demand for oral solid dosage forms due to their convenience, cost-efficiency, and patient compliance. Strong presence of generic drug manufacturers, increasing chronic disease prevalence, and advanced manufacturing technologies further boost large-scale tablet production, supporting significant market growth.

 

• The cementless fixation segment dominated the market in 2025 and holds the largest market share, accounting for approximately 49.9% during the forecast period.

Based on the fixation type, the hip replacement devices market is divided into cemented fixation, cementless fixation, and hybrid fixation. Among these, the cementless fixation segment dominated the market in 2025 and holds the largest market share, accounting for approximately 49.9% during the forecast period. The cementless fixation segment in the U.K. is driven by strong demand for convenient and non-invasive drug delivery systems, particularly for chronic disease management. High consumption of generics and OTC drugs, well-established pharmaceutical manufacturing infrastructure, and continuous innovation in oral formulations further support sustained market growth.

 

• The hospitals segment dominated the market in 2025 and holds the largest market share accounting for approximately 70% during the forecast period.

Based on the end-user, the hip replacement devices market is divided hospitals, ambulatory surgical centers, orthopedic clinics, and rehabilitation centers. Among these, the hospitals segment dominated the market in 2025 and holds the largest market share accounting for approximately 70% during the forecast period. The oral dosage forms segment in the U.K. is driven by strong demand for convenient and non-invasive drug delivery systems, particularly for chronic disease management. High consumption of generics and OTC drugs, well-established pharmaceutical manufacturing infrastructure, and continuous innovation in oral formulations further support sustained market growth.

 

Recent Development

In January 2026, the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) had reached record highs in medical device testing approvals. A fee waiver pilot launched to encouraged small UK firms and startups to enter the hip innovation space, boosting local orthopedic development.

In December 2025, the NHS enforced new "value-based procurement" guidelines. This has forced manufacturers to move from being "device sellers" to "service partners." Alliances now often include providing hospitals with managed equipment services (MES) and long-term data tracking of patient outcomes.

 

Competitive Analysis

The report offers the appropriate analysis of the key organisations/companies involved within the United Kingdom hip replacement devices market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

Top Key Companies in the United Kingdom Hip Replacement Devices Market

• Zimmer Biomet
• DePuy Synthes
• Stryker Corporation
• Smith & Nephew
• B. Braun Melsungen AG
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at the United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom hip replacement devices market based on the below-mentioned segments

 

United Kingdom United Kingdom Excipients market, By Product Type

• Total Hip Replacement Implants
• Partial Hip Replacement (Hemiarthroplasty)
• Hip Resurfacing Implants
• Revision Hip Replacement Implants

 

United Kingdom United Kingdom Excipients market, By Material Type

• Metal-on-Metal
• Metal-on-Polyethylene
• Ceramic-on-Polyethylene
• Ceramic-on-Ceramic

 

United Kingdom United Kingdom Excipients market, By Fixation Type

• Cemented Fixation
• Cementless Fixation
• Hybrid Fixation

 

United Kingdom United Kingdom Excipients market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Orthopedic Clinics
• Rehabilitation Centers

 

Frequently Asked Questions (FAQ)

Q. How is patient demand influencing innovation in the United Kingdom hip replacement devices market?

A. Patient demand is increasingly shaping innovation in the UK hip replacement devices market, with individuals seeking faster recovery, reduced pain, and longer-lasting implants. This has encouraged manufacturers to focus on minimally invasive surgical techniques, enhanced implant ergonomics, and improved post-operative rehabilitation solutions, ultimately driving patient-centric product development.

 

Q. What role do private healthcare providers play in the United Kingdom hip replacement devices market?

A. Private healthcare providers play a significant role by reducing pressure on public healthcare systems and offering quicker access to hip replacement surgeries. They often adopt advanced technologies faster than public institutions, thereby accelerating the adoption of premium implants and innovative surgical solutions within the overall market.

 

Q. How does regulatory compliance impact product launches in the United Kingdom hip replacement devices market?

A Regulatory compliance in the UK ensures high safety and quality standards, but it can also lengthen product approval timelines. Strict guidelines from authorities require extensive clinical validation, which may delay market entry but ultimately enhances trust among healthcare providers and patients.

 

Q. What opportunities exist for emerging companies in the United Kingdom hip replacement devices market?

A. Emerging companies have opportunities in niche areas such as personalized implants, digital surgical planning tools, and smart implant technologies. With growing support for innovation and startups, smaller firms can collaborate with healthcare providers to introduce cost-effective and technologically advanced solutions, gaining competitive advantage in the evolving market.